Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 262

The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.

Amyloid β‐peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease

Verdier, Yann, Zarándi, Márta, Penke, Botond·2004·Journal of Peptide Science

Abstract

The extracellular accumulation of amyloid‐beta (Aβ) in neuritic plaques is one of the characteristic hallmarks of Alzheimer's disease (AD), a progressive dementing neurodegenerative disorder of the elderly. By virtue of its structure, Aβ is able to bind to a variety of biomolecules, including lipids, proteins and proteoglycans. The binding of the various forms of Aβ (soluble or fibrillar) to plasma membranes has been studied with regard to the direct toxicity of Aβ to neurons, and the activation of a local inflammation phase involving microglia. The binding of Aβ to membrane lipids facilitates Aβ fibrillation, which in turn disturbs the structure and function of the membranes, such as membrane fluidity or the formation of ion channels. A subset of membrane proteins binds Aβ. The serpin‐enzyme complex receptor (SEC‐R) and the insulin receptor can bind the monomeric form of Aβ. The α7nicotinic acetylcholine receptor (α7nAChR), integrins, RAGE (receptor for advanced glycosylation end‐products) and FPRL1 (formyl peptide receptor‐like 1) are able to bind the monomeric and fibrillar forms of Aβ. In addition, APP (amyloid precursor protein), the NMDA‐R (N‐methyl‐D‐aspartate receptor), the P75 neurotrophin receptor (P75NTR), the CLAC‐P/collagen type XXV (collagen‐like Alzheimer amyloid plaque component precursor/collagen XXV), the scavenger receptors A, BI (SR‐A, SR‐BI) and CD36, a complex involving CD36, α 6 β 1–integrin and CD47 have been reported to bind the fibrillar form of Aβ. Heparan sulfate proteoglycans have also been described as cell‐surface binding sites for Aβ. The various effects of Aβ binding to these membrane molecules are discussed. Copyright © 2004 European Peptide Society and John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/psc.573

Cites

143 of 143 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 143 references

Cited by

See all 262

Metadata

Authors
Verdier, Y., Zarándi, M., & Penke, B.
Venue
Journal of Peptide Science
Publisher
Wiley
Published
2004-04-26
Volume
10
Issue
5
Pages
229-248
ISSN
  • 1075-2617 (ISSN-L)
  • 1099-1387
OpenAlex
W2029651181
Cited by
262
References
143
FWCI
8.93
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyloid β‐peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. https://app.cochat.ai/papers/10.1002/psc.573
The paper
Verdier, Y., Zarándi, M., & Penke, B. (2004). Amyloid β‐peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. Journal of Peptide Science. https://doi.org/10.1002/psc.573

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.